ClinicalTrials.gg
RecruitingNCT06025253PINTAUpdated Jul 21, 2026

PINTA - Prophylactic Incisional Negative Pressure Therapy for Major Amputations

An interventional study of Negative Pressure Wound Therapy and Standard Wound Dressing in Wound Surgical, Wound Infection and Cosmesis, sponsored by Royal College of Surgeons, Ireland. Recruiting at 7 sites in Ireland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-21.

Sponsored by Royal College of Surgeons, Ireland · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Mar 2024; still recruiting 2 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
728
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Post-operative wound issues in abdominal surgery have a significant impact on patient outcomes. This study is taking place to investigate if Negative Pressure Wound Therapy (NPWT) dressings reduces Surgical Site Infections, post surgical complications and improves scar appearance compared to standard dressings.

Read the detailed description

Many factors influence the risk of wound complications. Notably, the presence of unreconstructed proximal occlusive arterial disease is a major influence on stump healing. Patient factors such as smoking, diabetes, obesity, malnutrition and chronic kidney disease are non-modifiable, particularly in the short-term setting. However, surgical factors may be altered in an effort to reduce the risk of wound complications.

One option amenable to alteration is what dressing is applied to the closed incision upon procedure completion. The type of dressing may influence factors such as bacterial access to the wound, the development of collections of blood or fluid in the wound or fluid oozing from the wound. Collectively, these wound factors increase the risk of wound infection. Therefore, dressings which reduce these factors have the potential to reduce wound breakdown, thereby reducing the burden for patients and healthcare systems.

The investigators propose to conduct a multicentre randomised controlled trial comparing prophylactic single-use negative pressure wound therapy with standard dressings in patients with a closed incision following major lower extremity amputation in terms of SSI incidence, wound healing complications and scar appearance, patient quality of life and financial impact on the patient and healthcare system.

02

Conditions studied

  • Wound Surgical
  • Wound Infection
  • Cosmesis

Keywords

  • Negative Pressure Wound Therapy
  • Surgical Site Infection
  • Post-operative Complications
  • Health Economics
  • CoPaQ
  • WoundQol
03

In context

Surgical Wound

315 studies on the registry are indexed under Surgical Wound; 57 are open to participants now.

This study's planned enrollment of 728 is above the median of 66 across 242 interventional studies indexed under Surgical Wound.

Browse Surgical Wound studies →

Lead sponsor

Royal College of Surgeons, Ireland is the lead sponsor of 93 studies on the registry; 44 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18 years or older;
  • Patients undergoing major lower extremity amputation, including below-knee amputation, through-knee amputation and above-knee amputation, for any indication;
  • Patients with primary closure of the surgical incision using either interrupted or continuous sutures

Exclusion criteria

Exclusion Criteria:

  • Patients \<18 years;
  • Women who are pregnant and/or breast-feeding;
  • Patients with amputations performed without primary skin closure, including guillotine amputations, amputations deliberately left open for drainage purposes and amputations with soft tissues defects at the stump;
  • Patients with amputations where skin glue is the only means of skin closure
  • Patients with a clinically absent femoral pulse
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
728 participants (estimated)

Study arms

  • Experimental
    Negative Pressure Wound Therapy.

    Application of a negative wound pressure therapy dressing to the wound post major lower extremity amputation

    Device: Negative Pressure Wound Therapy

  • Active comparator
    Standard Wound dressing

    Application of sterile standard gauze dressing to the wound post major lower extremity amputation

    Device: Standard Wound Dressing

Interventions

  • DeviceNegative Pressure Wound Therapy

    Application of negative-pressure wound therapy (NPWT) post major lower extremity amputation

  • DeviceStandard Wound Dressing

    Application of standard wound dressing post major lower extremity amputation

06

What researchers measure

Primary outcomes

  1. Presence of wound complications following amputation between NPWT and standard dressings

    Infection(deep or superficial), wound dehiscence, partial (fascia intact), complete (fascia breached), seroma, haematoma or stump necrosis.

    Time frame: 1 month following surgery

Secondary outcomes

  1. Number of days to discharge

    Length of time patient is in hospital from date of surgery to date of discharge

    Time frame: 6 months following surgery

  2. Rate of re-admission

    Number of re-admissions to the hospital from date of surgery

    Time frame: 1 Month following surgery

  3. Health-related quality of life with the EuroQol-5 dimensions five level index questionnaire (EQ-5D-5L)

    The questionnaire covers five dimensions of health: mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. Each dimension has 5 levels: no problems (1), slight problems (2), moderate problems (3), severe problems (4) and extreme problems (5). The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. The raw scores are also converted to an EQ-5D index value using a scoring algorithm (British tariff) ranging from -0.594 (worst perceived health state) to 1.00 (best perceived health state)

    Time frame: Baseline

  4. Health-related quality of life with the EuroQol-5 dimensions five level index questionnaire (EQ-5D-5L)

    The questionnaire covers five dimensions of health: mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. Each dimension has 5 levels: no problems (1), slight problems (2), moderate problems (3), severe problems (4) and extreme problems (5). The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. The raw scores are also converted to an EQ-5D index value using a scoring algorithm (British tariff) ranging from -0.594 (worst perceived health state) to 1.00 (best perceived health state)

    Time frame: 1 month following surgery

  5. Health-related quality of life with the EuroQol-5 dimensions five level index questionnaire (EQ-5D-5L)

    The questionnaire covers five dimensions of health: mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. Each dimension has 5 levels: no problems (1), slight problems (2), moderate problems (3), severe problems (4) and extreme problems (5). The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. The raw scores are also converted to an EQ-5D index value using a scoring algorithm (British tariff) ranging from -0.594 (worst perceived health state) to 1.00 (best perceived health state)

    Time frame: 3 months following surgery

  6. Health-related quality of life with the EuroQol-5 dimensions five level index questionnaire (EQ-5D-5L)

    The questionnaire covers five dimensions of health: mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. Each dimension has 5 levels: no problems (1), slight problems (2), moderate problems (3), severe problems (4) and extreme problems (5). The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. The raw scores are also converted to an EQ-5D index value using a scoring algorithm (British tariff) ranging from -0.594 (worst perceived health state) to 1.00 (best perceived health state)

    Time frame: 6 months following surgery

  7. Wound-QoL (Questionnaire on quality of life with chronic wounds)

    Wound-QoL (Questionnaire on quality of life with chronic wounds) measures the disease-specific, health-related quality of life of patients with chronic wounds. It can be used in clinical and observational studies as well as in daily practice. The primary endpoint is the reduction of more than 0.4 points in the overall score of the Wound-Qol quality of life questionnaire between D0 and D14.

    Time frame: 1 month following surgery

  8. Wound-QoL (Questionnaire on quality of life with chronic wounds)

    Wound-QoL (Questionnaire on quality of life with chronic wounds) measures the disease-specific, health-related quality of life of patients with chronic wounds. It can be used in clinical and observational studies as well as in daily practice. The primary endpoint is the reduction of more than 0.4 points in the overall score of the Wound-Qol quality of life questionnaire between D0 and D14.

    Time frame: 3 months following surgery

  9. Wound-QoL (Questionnaire on quality of life with chronic wounds)

    Wound-QoL (Questionnaire on quality of life with chronic wounds) measures the disease-specific, health-related quality of life of patients with chronic wounds. It can be used in clinical and observational studies as well as in daily practice. The primary endpoint is the reduction of more than 0.4 points in the overall score of the Wound-Qol quality of life questionnaire between D0 and D14.

    Time frame: 6 months following surgery

  10. Health-related out-of- Pocket Costs assessed using the Costs for Patients Questionnaire (CoPaQ)

    The CoPaQ measures patient and caregivers out-of-pocket expenses (direct and indirect) associated with a health condition

    Time frame: 1 Month following surgery

  11. Health-related out-of- Pocket Costs assessed using the Costs for Patients Questionnaire (CoPaQ)

    The CoPaQ measures patient and caregivers out-of-pocket expenses (direct and indirect) associated with a health condition

    Time frame: 3 Months following surgery

  12. Health-related out-of- Pocket Costs assessed using the Costs for Patients Questionnaire (CoPaQ)

    The CoPaQ measures patient and caregivers out-of-pocket expenses (direct and indirect) associated with a health condition

    Time frame: 6 Months following surgery

  13. Rate of Re-operation

    Number of re-operations undertaken from date of surgery

    Time frame: 1 Month following surgery

07

Study locations

7 of 7 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06025253
Lead sponsor
Royal College of Surgeons, Ireland
Responsible party
Sponsor
First posted
Sep 6, 2023
Start date
Mar 1, 2024
Primary completion
Jul 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Jul 21, 2026

Study contacts

Stewart Walsh
Contact
stewartredmond.walsh@universityofgalway.ie
353 915 2422
Megan Foley
Contact
meganpfoley@rcsi.com
353 915 2422
Stewart Walsh, Prof
principal investigator · University Hospital Galway (UHG)

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion